Form4insider filings, from the source

Company · CIK 0000010795 · SIC 3841 — Surgical & Medical Instruments & Apparatus · NYSE

BECTON DICKINSON & CO · BDX

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $2.0M · 8net −$2.0M
$10k$10k$100k$100k$1M$1MbuyssalesSep 2024Jan 2025May 2025Sep 2025Jan 2026May 2026Sep 2026

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 2, 2026 FForm 4 →Sep 3, 7:24 pm EDTVitor RoqueEVP & Chief Financial Officer190——8,041—
Aug 26, 2026 SForm 4 →Aug 27, 4:28 pm EDTMichael FeldEVP, Chief Revenue Officer165$188.49$31,10119,720−0.83%10b5-1
Aug 20, 2026 FForm 4 →Aug 24, 4:19 pm EDTMichael FeldEVP, Chief Revenue Officer1,049——19,885—
Aug 13, 2026 SForm 4 →Aug 14, 4:36 pm EDTThomas E Polen Jr.Chairman, CEO and President, Director4,152$185.00$768,120110,163−3.63%10b5-1
Aug 13, 2026 DMForm 4 →Aug 14, 4:36 pm EDTThomas E Polen Jr.Chairman, CEO and President, Director82,404$175.68$14,476,556114,315—10b5-1
Aug 11, 2026 SForm 4 →Aug 12, 5:27 pm EDTRoland GoetteEVP and President, EMEA2,438$180.84$440,88814,856−14.1%
Jul 27, 2026 SForm 4 →Jul 28, 11:16 am EDTMichael FeldEVP, Chief Revenue Officer75$157.13$11,78520,934−0.36%10b5-1
Jul 1, 2026 AFForm 4 →Jul 6, 3:16 pm EDTBilal MuhsinEVP & President Connected Care16,277——41,359—
Jun 26, 2026 SForm 4 →Jun 26, 8:47 pm EDTMichael FeldEVP, Chief Revenue Officer75$152.80$11,46021,009−0.36%10b5-1
Jun 24, 2026 SForm 4 →Jun 25, 10:16 am EDTMichael David GarrisonEVP & Pres Med.Essntl&BioPharm1,100$145.66$160,22613,172−7.71%10b5-1
Jun 10, 2026 SForm 4 →Jun 11, 5:21 pm EDTMichael David GarrisonEVP & Pres Med.Essntl&BioPharm1,100$151.48$166,62814,272−7.16%10b5-1
Jun 1, 2026 SForm 4 →Jun 3, 12:44 pm EDTThomas E Polen Jr.Chairman, CEO and President, Director2,764$146.35$404,511110,163−2.45%10b5-1
Jun 1, 2026 DMForm 4 →Jun 3, 12:44 pm EDTThomas E Polen Jr.Chairman, CEO and President, Director37,654$135.42$5,099,154108,235—10b5-1

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Aug 13, 2026 MForm 4 →Aug 14, 4:36 pm EDTThomas E Polen Jr.Chairman, CEO and President, Director43,278——0—10b5-1
Aug 6, 2026 AForm 4 →Aug 6, 4:47 pm EDTRobert Luther HuffinesDirector189$165.62$31,302595—
Aug 6, 2026 AForm 4 →Aug 6, 4:47 pm EDTCarrie L ByingtonDirector94$165.62$15,5683,810—
Jun 1, 2026 MForm 4 →Jun 3, 12:44 pm EDTThomas E Polen Jr.Chairman, CEO and President, Director20,209——0—10b5-1